Total Payments
$1,282
2024 Payments
$325.45
Companies
20
Transactions
87
Medicare Patients
669
Medicare Billing
$44,118
Payment Breakdown by Category
Food & Beverage$1,282 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,282 | 87 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $362.42 | 30 | $0 (2024) |
| ABBVIE INC. | $162.94 | 4 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $116.37 | 9 | $0 (2020) |
| Astellas Pharma US Inc | $104.14 | 6 | $0 (2024) |
| Amarin Pharma Inc. | $102.44 | 8 | $0 (2020) |
| Lilly USA, LLC | $92.63 | 6 | $0 (2024) |
| Merck Sharp & Dohme LLC | $66.80 | 5 | $0 (2024) |
| GlaxoSmithKline, LLC. | $61.21 | 4 | $0 (2024) |
| PFIZER INC. | $32.36 | 2 | $0 (2024) |
| Nalpropion Pharmaceuticals LLC | $28.32 | 2 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $325.45 | 13 | ABBVIE INC. ($148.75) |
| 2023 | $90.75 | 5 | Astellas Pharma US Inc ($38.58) |
| 2022 | $85.19 | 6 | Novo Nordisk Inc ($70.35) |
| 2020 | $169.91 | 13 | Amarin Pharma Inc. ($50.06) |
| 2019 | $415.61 | 35 | Novo Nordisk Inc ($154.49) |
| 2018 | $195.04 | 15 | Novo Nordisk Inc ($65.97) |
All Payment Transactions
87 individual payment records from CMS Open Payments — Page 3 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/12/2019 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $12.00 | General |
| Category: Respiratory | ||||||
| 08/30/2019 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $11.39 | General |
| Category: Obesity | ||||||
| 08/27/2019 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Food and Beverage | In-kind items and services | $14.15 | General |
| Category: Respiratory | ||||||
| 08/05/2019 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $14.02 | General |
| 07/30/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $5.40 | General |
| Category: Diabetes | ||||||
| 06/24/2019 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $12.50 | General |
| Category: Respiratory | ||||||
| 06/19/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $6.82 | General |
| Category: Diabetes | ||||||
| 06/07/2019 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $11.92 | General |
| Category: Obesity | ||||||
| 05/17/2019 | Novo Nordisk Inc | Tresiba (Drug), Victoza, Xultophy 100/3.6 | Food and Beverage | In-kind items and services | $11.64 | General |
| Category: Diabetes | ||||||
| 05/08/2019 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, ASMANEX | Food and Beverage | In-kind items and services | $14.13 | General |
| Category: ENDOCRINOLOGY | ||||||
| 04/29/2019 | EISAI INC. | Belviq (Drug) | Food and Beverage | Cash or cash equivalent | $11.69 | General |
| Category: Nutrition and Weight Loss | ||||||
| 04/26/2019 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $13.01 | General |
| Category: Diabetes | ||||||
| 04/19/2019 | Novo Nordisk Inc | Tresiba (Drug), Victoza, Xultophy 100/3.6 | Food and Beverage | In-kind items and services | $11.22 | General |
| Category: Diabetes | ||||||
| 04/12/2019 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $14.41 | General |
| Category: Diabetes | ||||||
| 04/08/2019 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug), Bystolic | Food and Beverage | Cash or cash equivalent | $11.16 | General |
| Category: Cardiovascular | ||||||
| 04/03/2019 | Nalpropion Pharmaceuticals LLC | CONTRAVE (Drug) | Food and Beverage | In-kind items and services | $14.46 | General |
| Category: OBESITY | ||||||
| 03/28/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.56 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/22/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $11.75 | General |
| Category: Diabetes | ||||||
| 03/01/2019 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: Diabetes | ||||||
| 02/25/2019 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $12.43 | General |
| Category: Respiratory | ||||||
| 02/01/2019 | Nalpropion Pharmaceuticals LLC | CONTRAVE (Drug) | Food and Beverage | In-kind items and services | $13.86 | General |
| Category: OBESITY | ||||||
| 01/18/2019 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $13.02 | General |
| Category: Hypertriglyceridemia | ||||||
| 11/26/2018 | Merck Sharp & Dohme Corporation | BELSOMRA (Drug), JANUMET XR, STEGLATRO | Food and Beverage | In-kind items and services | $11.55 | General |
| Category: NEUROSCIENCE | ||||||
| 11/19/2018 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: Diabetes | ||||||
| 11/08/2018 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $14.10 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 169 | 241 | $55,980 | $11,990 |
| 2022 | 6 | 163 | 226 | $48,539 | $10,318 |
| 2021 | 7 | 191 | 257 | $53,949 | $12,981 |
| 2020 | 6 | 146 | 186 | $32,546 | $8,828 |
Total Patients
669
Total Services
910
Medicare Billing
$44,118
Procedure Codes
24
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 92 | 160 | $45,440 | $8,377 | 18.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 28 | 32 | $6,400 | $1,621 | 25.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 17 | 17 | $2,380 | $1,223 | 51.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 20 | 20 | $1,100 | $657.40 | 59.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 12 | 12 | $660.00 | $111.60 | 16.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 88 | 142 | $40,328 | $7,749 | 19.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 14 | 14 | $1,960 | $959.56 | 49.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 19 | 22 | $4,400 | $888.30 | 20.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 16 | 16 | $720.00 | $519.84 | 72.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 14 | 15 | $825.00 | $150.03 | 18.2% |
| 81002 | Urinalysis, manual test | Office | 2022 | 12 | 17 | $306.00 | $51.78 | 16.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 78 | 135 | $37,908 | $7,816 | 20.6% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2021 | 14 | 14 | $4,004 | $1,739 | 43.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 29 | 34 | $6,722 | $1,446 | 21.5% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 18 | 19 | $2,660 | $1,162 | 43.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 22 | 23 | $1,035 | $413.30 | 39.9% |
| G0009 | Administration of pneumococcal vaccine | Office | 2021 | 14 | 14 | $630.00 | $261.70 | 41.5% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 16 | 18 | $990.00 | $144.10 | 14.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 59 | 88 | $20,768 | $5,176 | 24.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 28 | 36 | $5,796 | $1,516 | 26.1% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 17 | 17 | $2,380 | $1,037 | 43.6% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 11 | 13 | $2,032 | $586.37 | 28.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 19 | 19 | $855.00 | $348.65 | 40.8% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 12 | 13 | $715.00 | $165.28 | 23.1% |
About Dr. Sangita Doshi, MD
Dr. Sangita Doshi, MD is a Family Medicine healthcare provider based in Haddon Heights, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1376505057.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sangita Doshi, MD has received a total of $1,282 in payments from pharmaceutical and medical device companies, with $325.45 received in 2024. These payments were reported across 87 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($1,282).
As a Medicare-enrolled provider, Doshi has provided services to 669 Medicare beneficiaries, totaling 910 services with total Medicare billing of $44,118. Data is available for 4 years (2020–2023), covering 24 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Other Specialties Family Medicine
- Location Haddon Heights, NJ
- Active Since 04/06/2006
- Last Updated 10/19/2020
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1376505057
Products in Payments
- Tresiba (Drug) $106.24
- Vascepa (Drug) $102.44
- Saxenda (Drug) $100.00
- Veozah (Drug) $80.39
- Ozempic (Drug) $72.35
- Rybelsus (Drug) $68.90
- SHINGRIX (Biological) $61.21
- SYMBICORT (Drug) $51.03
- UBRELVY (Drug) $48.87
- CONTRAVE (Drug) $28.32
- FARXIGA (Drug) $26.17
- Belviq (Drug) $26.02
- MOUNJARO (Drug) $26.00
- BASAGLAR (Drug) $25.43
- JANUVIA (Drug) $24.93
- Cologuard Collection Kit (Device) $20.52
- PREVNAR 20 (Biological) $19.05
- GARDASIL (Biological) $15.48
- AUVI-Q (Drug) $14.99
- GARDASIL 9 (Biological) $14.84
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Haddon Heights
Beth Greenwood, Md, MD
Family Medicine — Payments: $1,129
Family Medicine $1,129
Leena Jacob, D.o, D.O
Family Medicine — Payments: $640.59
Family Medicine $640.59
Nancy Koshy
Family Medicine — Payments: $462.15
Family Medicine $462.15
Dr. Frank Anthony Aliganga, Md, MD
Family Medicine — Payments: $61.92
Family Medicine $61.92
Dr. Alexander Higgins, M.d, M.D
Family Medicine — Payments: $47.88
Family Medicine $47.88
Dr. Mary Willard, M.d, M.D
Family Medicine
Family Medicine